Your browser doesn't support javascript.
loading
Specificity and 6-month durability of immune responses induced by DNA and recombinant modified vaccinia Ankara vaccines expressing HIV-1 virus-like particles.
Goepfert, Paul A; Elizaga, Marnie L; Seaton, Kelly; Tomaras, Georgia D; Montefiori, David C; Sato, Alicia; Hural, John; DeRosa, Stephen C; Kalams, Spyros A; McElrath, M Juliana; Keefer, Michael C; Baden, Lindsey R; Lama, Javier R; Sanchez, Jorge; Mulligan, Mark J; Buchbinder, Susan P; Hammer, Scott M; Koblin, Beryl A; Pensiero, Michael; Butler, Chris; Moss, Bernard; Robinson, Harriet L.
Afiliação
  • Goepfert PA; Department of Medicine, University of Alabama at Birmingham.
  • Elizaga ML; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center.
  • Seaton K; Laboratory for AIDS Vaccine Research and Development, Department of Surgery, Duke University Medical Center, Durham, North Carolina.
  • Tomaras GD; Laboratory for AIDS Vaccine Research and Development, Department of Surgery, Duke University Medical Center, Durham, North Carolina.
  • Montefiori DC; Laboratory for AIDS Vaccine Research and Development, Department of Surgery, Duke University Medical Center, Durham, North Carolina.
  • Sato A; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center.
  • Hural J; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center.
  • DeRosa SC; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center University of Washington, Seattle, Washington.
  • Kalams SA; Vanderbilt University School of Medicine, Nashville, Tennessee.
  • McElrath MJ; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center University of Washington, Seattle, Washington.
  • Keefer MC; University of Rochester School of Medicine and Dentistry, Rochester.
  • Baden LR; Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
  • Lama JR; Asociacion Civil IMPACTA Salud y Educacion, Lima, Peru.
  • Sanchez J; Asociacion Civil IMPACTA Salud y Educacion, Lima, Peru.
  • Mulligan MJ; Division of Infectious Diseases, Emory University, Atlanta.
  • Buchbinder SP; Bridge HIV, San Francisco Department of Public Health, California.
  • Hammer SM; Columbia University.
  • Koblin BA; New York Blood Center, New York, New York.
  • Pensiero M; Division of AIDS.
  • Butler C; Division of AIDS.
  • Moss B; Laboratory of Viral Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland.
  • Robinson HL; GeoVax Inc., Smyrna, Georgia.
J Infect Dis ; 210(1): 99-110, 2014 Jul 01.
Article em En | MEDLINE | ID: mdl-24403557
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Portadores de Fármacos / HIV-1 / Vacinas contra a AIDS / Produtos do Gene env do Vírus da Imunodeficiência Humana / Vacinas de Partículas Semelhantes a Vírus Tipo de estudo: Clinical_trials Limite: Adolescent / Adult / Female / Humans / Male / Middle aged Idioma: En Revista: J Infect Dis Ano de publicação: 2014 Tipo de documento: Article País de publicação: Estados Unidos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Portadores de Fármacos / HIV-1 / Vacinas contra a AIDS / Produtos do Gene env do Vírus da Imunodeficiência Humana / Vacinas de Partículas Semelhantes a Vírus Tipo de estudo: Clinical_trials Limite: Adolescent / Adult / Female / Humans / Male / Middle aged Idioma: En Revista: J Infect Dis Ano de publicação: 2014 Tipo de documento: Article País de publicação: Estados Unidos